American Journal of Clinical Nutrition, Vol 60, 397-402, Copyright © 1994 by The American Society for Clinical Nutrition, Inc

ORIGINAL RESEARCH COMMUNICATIONS

Relative bioavailability of RRR- and all-rac-alpha-tocopheryl acetate in humans: studies using deuterated compounds

RV Acuff, SS Thedford, NN Hidiroglou, AM Papas and TA Odom Jr
Department of Surgery, East Tennessee State University, Johnson City 37614-0575.

Vitamin E in nutritional supplements in its most common form is alpha- tocopheryl acetate. Available stereoisomeric forms are RRR- (1 stereoisomer) and all-rac- (8 stereoisomers). We evaluated the relative bioavailability of RRR- and all-rac-alpha-tocopheryl acetate using the deuterium-labeled isotopes [5-CD3] 2R, 4'R and 8'R-alpha-tocopheryl acetate (d3), and [5,7-(CD3)2]-all-rac-alpha-tocopheryl acetate (d6). Six adults (three males, three females), aged 25-59 y, received 150 mg each of d3 and d6 for 11 consecutive days. Blood samples were collected on days -1, 0, 1-11, 13, 14, 20, 25, 30, 60, 74, 88, 102, 122, and 137. Plasma and red blood cell tocopherol were evaluated by using HPLC and gas chromatography/mass spectrometry to distinguish between d3 and d6 tocopherols. Cholesterol, triglycerides, and LDL and HDL cholesterol were measured. Relative bioavailability of d3 when compared with d6 was 2.0 +/- 0.06 when area under the plasma time concentration curve (AUC d3/d6) by trapezoidal rule (P < 0.05) was used. Correcting for lipid yielded the same finding. Unlabeled tocopherol (d0) decreased (P < 0.05) with vitamin E administration. It was concluded that the ratio of bioavailability of RRR-/all-rac-alpha-tocopheryl acetate is significantly greater than the currently accepted ratio of 1.36.

This article has been cited by other articles:

				A. J Clifford, F. F de Moura, C. C Ho, J. C Chuang, J. Follett, J. G Fadel, and J. A Novotny A feasibility study quantifying in vivo human {alpha}-tocopherol metabolism Am. J. Clinical Nutrition, December 1, 2006; 84(6): 1430 - 1441. [Abstract] [Full Text] [PDF]

				A. R. Proteggente, R. Turner, J. Majewicz, G. Rimbach, A. M. Minihane, K. Kramer, and J. K. Lodge Noncompetitive Plasma Biokinetics of Deuterium-Labeled Natural and Synthetic {alpha}-Tocopherol in Healthy Men with an apoE4 Genotype J. Nutr., May 1, 2005; 135(5): 1063 - 1069. [Abstract] [Full Text] [PDF]

				R. S Bruno, R. Ramakrishnan, T. J Montine, T. M Bray, and M. G Traber {alpha}-Tocopherol disappearance is faster in cigarette smokers and is inversely related to their ascorbic acid status Am. J. Clinical Nutrition, January 1, 2005; 81(1): 95 - 103. [Abstract] [Full Text] [PDF]

				S. Landvik Vitamin E from supplements has good bioavailability Am. J. Clinical Nutrition, September 1, 2004; 80(3): 784 - 785. [Full Text] [PDF]

				W. L Stone, I. LeClair, T. Ponder, G. Baggs, and B. B. Reis Infants discriminate between natural and synthetic vitamin E Am. J. Clinical Nutrition, April 1, 2003; 77(4): 899 - 906. [Abstract] [Full Text] [PDF]

				C. Lauridsen, H. Engel, S. K. Jensen, A. M. Craig, and M. G. Traber Lactating Sows and Suckling Piglets Preferentially Incorporate RRR- over All-rac-{alpha}-Tocopherol into Milk, Plasma and Tissues J. Nutr., June 1, 2002; 132(6): 1258 - 1264. [Abstract] [Full Text] [PDF]

				F. Violi, F. Micheletta, and L. Iuliano Antioxidants and atherosclerosis Eur. Heart J. Suppl., March 1, 2002; 4(suppl_B): B17 - B21. [Abstract] [PDF]

				K. Hayes, A. Pronczuk, and D. Perlman Vitamin E in fortified cow milk uniquely enriches human plasma lipoproteins Am. J. Clinical Nutrition, August 1, 2001; 74(2): 211 - 218. [Abstract] [Full Text] [PDF]

				M. Schuelke, A. Elsner, B. Finckh, A. Kohlschütter, C. Hübner, and R. Brigelius-Flohé Urinary {alpha}-tocopherol metabolites in {alpha}-tocopherol transfer protein-deficient patients J. Lipid Res., October 1, 2000; 41(10): 1543 - 1551. [Abstract] [Full Text]

				R. BRIGELIUS-FLOHÉ and M. G. TRABER Vitamin E: function and metabolism FASEB J, July 1, 1999; 13(10): 1145 - 1155. [Abstract] [Full Text]